Across the African continent, a profound paradox defines the scientific landscape. While intellectual curiosity and academic output are expanding, the transition of these discoveries from the laboratory bench to the commercial market remains stalled within a persistent gap of untapped potential. Current data reveals a systemic attrition in the innovation pipeline: approximately 98% of university research remains limited to publications, failing to reach industrial validation or market entry [1].
To transform Africa’s research potential into a sovereign economic engine, we must address structural bottlenecks, including funding structures, human capital, institutions, capital markets, and policy frameworks that currently confine African brilliance to the ivory tower.
This research integrates qualitative insights from an in-depth interview with Wacim Ben Yahya, Head of the Technology Transfer Office (TTO) at the International University of Rabat (UIR), Morocco, providing context on institutional commercialization, TTO operations, and IP registration challenges.
I. Funding Constraints
1. Low R&D Intensity (GERD)
Africa’s Gross Expenditure on Research and Development (GERD) remains structurally low. On average, African countries invest approximately 0.45% of GDP in R&D, compared to a global average of 1.79% and below the African Union’s 1% GDP target [3,4]. This limits laboratory infrastructure, access to advanced research equipment, and sustained technology maturation beyond early-stage research.
Public underinvestment is compounded by high debt burdens. In roughly half of African countries, public debt exceeds 60% of GDP, with rising debt servicing costs potentially crowding out fiscal space for universities, research institutes, and R&D infrastructure [5,6,7]. At the same time, Business Enterprise Expenditure on R&D (BERD) remains below 0.1% of GDP in most African economies, reaching only 0.323% in South Africa, indicating weak private-sector engagement in research absorption and commercialization [8].
Recommended actions
- Establish multi-stakeholder R&D funding platforms that pool public budgets, private sector capital, and international resources to finance targeted research, technology maturation, and commercialization.
- Introduce government matching-fund mechanisms that systematically leverage external donor funding and private investment into domestic R&D and translational research.
- Stimulate private-sector R&D and commercialization through targeted fiscal incentives, structured co-investment schemes, and industry–innovator collaboration platforms that bridge research and market-ready technology.
- Expand debt relief frameworks through enhanced Debt Sustainability Analyses that explicitly safeguard fiscal space for R&D investment and technology transfer infrastructure [9].
2. External Funding Dependency
Across 45 African countries, over 80% of GERD is financed through external sources, creating deep dependency on donor funding [4]. While this has sustained research activity, it has also shaped research agendas toward global public goods, such as health and climate, rather than domestic industrial development and deep-tech commercialization.
External funding structures often prioritize publications and short project cycles over patents, prototypes, or commercialization outputs [10]. Research priorities set externally frequently diverge from local industrial needs, weakening linkages between researchers, firms, and SMEs [11]. In many cases, African researchers remain confined to data collection roles, while analytical control and intellectual property ownership are retained by external partners [10]. Shifts in donor priorities further undermine continuity in translational and commercialization-oriented research.
Recommended actions
- Strengthen research governance and market interfaces by investing in capable national research councils, technology transfer offices, and innovation agencies that protect IP locally and connect research to firms [4].
- Diversify research financing by mobilizing regional development banks, private sector co-investment, diaspora capital, and philanthropy to reduce over-reliance on external donors [12].
- Align external funding with national industrial strategies and AU Agenda 2063 through formal research compacts that ensure donor support complements, rather than dictates, domestic innovation priorities [4].
II. Human Capital Constraints
Low Researcher Density
Africa’s path to commercialization is primarily stifled by systemic human capital deficits. This talent-related bottleneck is particularly acute in Sub-Saharan Africa, where the scarcity of researchers creates a critical gap between academic output and market application.
Sub-Saharan Africa has one of the lowest researcher densities globally, averaging approximately 90 researchers per million inhabitants, compared to a global average of 1,420 per million [3]. This limits the availability of skilled personnel required for sustained R&D activity and commercialization-oriented research.
Low researcher density constrains absorptive capacity and reduces opportunities for multidisciplinary collaboration, particularly in areas requiring coordinated technical, market, and regulatory expertise [3].
Recommended actions
- Expand graduate and doctoral training through increased scholarships and postgraduate programs in science, engineering, and technology to build a sustainable pipeline of commercialization-relevant researchers [3].
- Strengthen institutional retention mechanisms by offering competitive salaries, stable research funding, and structured mentorship to reduce researcher attrition and brain drain [3].
- Reinforce institutional capacity for applied research by supporting teams that integrate technical, market, and commercialization expertise rather than isolated academic specialization.
III. Institutional Bottlenecks & The Measurement Bias
1. Technology Transfer Office (TTO) Gaps
Many African universities operate nascent or under-resourced TTOs that lack commercialization expertise, legal capacity, and strong industry linkages [13,14]. In several cases, TTOs exist in name only, with limited staffing, funding, or strategic integration.
These structural bottlenecks are further reinforced by a persistent institutional mindset divide between research exploration and market exploitation. In Morocco, as Wacim Ben Yahya (Head of TTO, UIR) explains, “the research mindset is different from the entrepreneur mindset,” noting that academic systems remain driven primarily by discovery and publication rather than value creation or economic return. He frames this as a structural imbalance between “exploration, which is research, and exploitation, which is using that research.” This orientation extends beyond individual researchers, spanning “from top management of universities and research labs to interns working within research teams,” where “the goal is publication and creation of new knowledge, not exploitation.”
Institutional culture therefore continues to privilege publications over value creation, reinforcing a disconnect between academia and entrepreneurship. While this orientation is slowly evolving, progress remains uneven. Ben Yahya notes that universities were historically structured around two pillars, education and research, but are now incorporating a third mission centered on economic value creation. This shift has prompted the adoption of formal institutional IP policies that define ownership, valuation, transfer mechanisms, and revenue-sharing with inventors. However, these frameworks remain contested in practice.
A key point of friction concerns patenting versus publication dynamics. While interest in patenting is increasing “more and more researchers are moving towards patenting” implementation faces resistance at the laboratory level. Ben Yahya highlights the growing adoption of publication-freezing practices prior to patent filing, noting that “once an article is published, the patent cannot be done because it becomes public knowledge.” Although this is standard practice in mature innovation systems, it often meets internal opposition, as researchers perceive it as delaying academic output, a reaction that again reflects underlying mindset tensions.
Operationally, TTOs also face asymmetries in university–industry engagement. Corporations tend to act proactively, as Ben Yahya observes: “they know what they need, and when they need something, they go and pick it up.” Universities, by contrast, remain cautious in openly marketing their technologies, fearing misappropriation: “if we share solutions, they will pick them up and use them without going through a license.” This defensive posture reflects low institutional confidence in IP enforcement and is increasingly compounded by AI-related leakage risks, where technologies may be absorbed without disclosure.
These factors contribute to persistently low licensing outcomes. Even internationally, Ben Yahya stresses that such outcomes are structurally constrained rather than anomalous: “the numbers are very low internationally, not just in Morocco.” He estimates that licensing rates are typically “about 1%,” which he notes “is not something to be neglected; it requires a lot of work to reach,” and can reach “8% among top-performing institutions, with averages between 3% and 5%”. He attributes this gap not to weak performance but to a structural imbalance: “there is a mismatch between the reward and the risk universities are taking.” As he concludes, “universities need to learn more about how to take risks and cover them as well.” Corporations, by contrast, are structurally better positioned to absorb uncertainty and internalize high-risk innovation, while universities lack equivalent mechanisms to manage downside risk while capturing long-term value.
Recommended actions
- Build TTO capacity by funding dedicated commercialization staff, legal and IP expertise, and industry engagement functions within universities and research institutions [14].
- Institutionalize structured readiness frameworks that systematically assess technology, market, commercial, and management readiness, with explicit weighting toward market viability.
- Establish clear institutional incentives that reward TTOs and researchers for industry partnerships, R&D contracts, licensing, and co-development agreements [13].
- Integrate TTOs into national and institutional innovation strategies with performance metrics tied to startups created, licenses executed, and commercialization revenue generated [13].
2. IP Registration Costs and Fragmentation
Patent filing in Africa remains costly, fragmented, and complex, involving national systems alongside the African Regional Intellectual Property Organization (ARIPO) and the Organisation Africaine de la Propriété Intellectuelle (OAPI). Africa accounts for less than 1% of global patent applications, reflecting significant barriers to IP uptake and utilization [15,16,17].
High filing and maintenance costs discourage local innovators, while fragmented regimes increase administrative uncertainty. Weak IP protection and enforcement reduce confidence among innovators and investors, limiting commercialization activity [15,16,17].
Despite these constraints, emerging national mechanisms point to gradual change. Ben Yahya highlights Morocco’s recent IP Marketplace initiative, describing it as “a platform where universities and research labs publish patents for licensing, while industries publish their challenges and needs.” While adoption remains limited, “there are signals that the interest is there,” suggesting that awareness and trust, rather than demand, remain the binding constraints.
On the demand side, local industry interest is tangible but structured around co-development rather than standalone licensing. Ben Yahya reports frequent engagement with firms stating, “this is the problem we need to solve,” often coupled with unrealistic expectations regarding university funding capacity. Co-development has therefore emerged as the dominant transfer pathway, since “there is more chance to reach exactly what the corporate needs,” allowing joint decision-making beyond what academic literature alone can provide.
Sectoral demand is uneven but concentrated. According to Ben Yahya, healthcare shows the strongest pull for advanced technologies, followed by cleantech and mobility, with AI cutting across all sectors. However, these opportunities are constrained by the absence of patient capital. As he states, “I do not think we have patient capital,” noting that deep-tech development requires long timelines and substantial investment before commercial inflection points emerge.
Existing investment tends to align with corporate strategic priorities rather than open-ended technology risk. Ben Yahya characterizes this as “not really investment, but outsourcing R&D,” where capital is deployed only into technologies already aligned with fund backers’ interests. More broadly, corporations prefer to internalize R&D to retain control over high-risk technologies: “they want to keep control because the risk is very high.” This logic further constrains the external commercialization of university-originated deep technologies.
Recommended actions
- Harmonize and streamline patent procedures across ARIPO and OAPI member states to reduce administrative complexity, duplication, and uncertainty for innovators [16].
- Strengthen regional IP support services by expanding patent clinics and legal advisory centers that assist researchers in drafting, filing, and managing IP portfolios [16].
- Subsidize IP filing and maintenance costs through fee waivers or scaled pricing for startups and university inventors to lower financial barriers to early protection [17].
- Promote utility models and alternative, lower-cost IP protections for incremental and early-stage innovations while reforming academic incentives to value patents alongside publications [17].
3. Formal vs. Informal Knowledge Transfer: The Measurement Bias
Academic literature and institutional policies focus primarily on formal mechanisms such as patents and licenses, largely because these outputs are codified and easily measurable, yet this focus creates a pervasive "measurement bias" that ignores the most vital conduits of knowledge. For example in Morocco, the reality of this gap is stark; recent studies indicate that approximately 68% of technology transfer procedures are reported as informal, relying on individual initiatives and tacit exchange rather than structured institutional protocols [18].
This focus on the visible transaction obscures four dominant channels of hidden innovation that are critical for emerging ecosystems:
- Mobility of PhD Students and Postdoctoral Researchers: Mobility of PhD students and early-career researchers constitutes a critical informal channel of knowledge transfer. Through geographic and organizational mobility, doctoral researchers act as carriers of tacit knowledge, embedding practices, skills, and relational capital into host and home ecosystems. This “hidden pipe” of mobility enables sustained access to advanced research environments and long-lasting professional networks that continue to generate knowledge spillovers beyond the mobility period [19].
- Collaborative Research Projects: Many valuable industry–university partnerships function as informal collaborations built on interpersonal trust and ongoing interaction rather than legal bureaucracy. In such research partnerships, trust reduces the need for strict formal contracts, and coordination is often managed informally through regular meetings and mutual communication, rather than through structured legal frameworks [20].
- Industry-Funded PhDs: Programs like the industrial PhD provide early-career researchers with on-the-job training to acquire professional tacit knowledge and practically relevant methods. Evidence suggests that researchers supported by industrial funding outperform their peers in both the quantity and quality of subsequent scientific production, making this a high-impact channel for economic maturation [18, 21].
- Consulting and Expert Activities: Faculty members frequently provide direct advisory services to industry and government, solving technical bottlenecks or guiding policy through their specialized expertise. While these activities restore a sense of collective belonging and influence public debate, they are often viewed as "individual services" and are omitted from official technology transfer registries [20].
IV. Market and Capital Constraints
1. The “Valley of Death” and Misaligned Capital Instruments
African investment ecosystems prioritize fast-return sectors such as fintech, while deep-tech research commercialization requires longer time horizons and higher upfront capital. Equity-based venture capital structures with short fund lifecycles are poorly suited to these dynamics, leaving most university research outputs uncommercialized [1,2].
The absence of blended finance, non-dilutive instruments, and milestone-based funding contributes to discontinuities between public research funding and private investment, stranding prototypes before piloting or regulatory validation [22]. Limited exit markets further constrain investor appetite [23].
Recommended actions
- Deploy blended-finance seed vehicles that combine public, philanthropic, and DFI capital to absorb early technical and market risk in research-derived ventures.
- Expand proof-of-concept and translational funding programs that bridge the discontinuity between public research grants and private investment readiness.
- Introduce non-dilutive and hybrid financing instruments, including milestone-based grants, convertible grants, and revenue-based financing for ventures operating at TRL 4–7 [24].
- Anchor patient-capital funds with longer investment horizons and strengthen exit pathways through corporate venture capital, strategic procurement, and regional M&A platforms [23].
2. Insufficient Fund Sizes and Deep-Tech Investment Expertise
Most African venture and innovation funds remain too small to support capital-intensive, research-derived technologies across multiple funding rounds, particularly through TRL 3–7 stages [2]. Limited fund size reinforces investor bias toward low-capital sectors.
In parallel, many investors lack the technical expertise required to assess long-cycle, science-based ventures, reducing effective engagement with research institutions and limiting deal flow [26].
Recommended actions
- Anchor larger deep-tech commercialization funds using public and development finance capital to enable multi-round financing through high-cost TRL stages [25].
- Promote fund-of-funds and syndication models that pool capital across investors and reduce fragmentation in early-stage deep-tech financing.
- Deploy catalytic concessional and first-loss capital structures to make larger fund sizes viable and crowd in private investors.
- Build deep-tech investment capacity by training fund managers, embedding scientific advisors in investment teams, and strengthening research–investor collaboration mechanisms [26].
V. Policy Bottlenecks
1. Lack of Public Risk-Sharing Mechanisms
African innovation systems largely lack structured public instruments, such as first-loss capital, guarantees, and co-investment vehicles, designed to absorb early-stage commercialization risk. In their absence, private investors remain fully exposed to technical and market uncertainty, limiting participation in early TRL ventures [27].
Recommended actions
- Deploy first-loss guarantees and other public risk-absorption instruments to reduce early-stage technical and market risk faced by private investors.
- Establish structured public–private co-investment platforms that align incentives and crowd private capital into early TRL commercialization.
- Standardize risk-sharing instruments to enable replication, scalability, and institutional learning across sectors and countries.
- Integrate risk-sharing mechanisms into national innovation financing frameworks to close the gap between proof-of-concept and investor readiness [27].
2. Absence of Anchor Customers and Demand Pull
Research commercialization is further constrained by weak public procurement for innovation and limited participation by large firms as early buyers. Without anchor customers, research outputs lack early market validation and revenue signals, slowing adoption and scale [28].
Recommended actions
- Use strategic public procurement to act as an early buyer of research-derived innovations, providing initial revenue and market validation.
- Implement pre-commercial and forward-commitment procurement programs that guarantee future purchases once performance benchmarks are met.
- Encourage corporate anchor agreements in which large firms co-purchase or co-develop research outputs to generate early demand signals.
- Embed demand-side instruments within national innovation strategies to systematically pull research outputs into sustained commercial adoption [28].
Africa’s lab-to-market gap reflects systemic misalignment rather than isolated failure. Persistent underinvestment in R&D, heavy reliance on external funding, limited researcher density, weak commercialization institutions, misaligned capital instruments, and incomplete policy frameworks interact to keep research outputs disconnected from markets.
Bridging this gap requires coordinated action across the entire innovation system. Funding must support technology maturation, institutions must prioritize value creation, capital must align with long development cycles, and policy instruments must share risk and stimulate demand. Without such coherence, Africa’s growing research base will continue to expand in volume while remaining largely disconnected from industrial transformation and economic impact.
References
- Koya Capital Fund Analysis, 2025. Available here
- From Labs to Markets: Financing the Missing Middle in Africa’s Deep Tech Ecosystem, 2026, Medium. Available here
- Transforming Knowledge for Africa’s Future, 2025, UNESCO. Available here
- Biennial Report on the Review of the Implementation of Commitments Made Towards Africa’s Development, 2025, United Nations Monitoring Mechanism (UNMM). Available here
- Economic Development in Africa Report, 2024, UNCTAD. Available here
- Distributional Crowding Out Effects of Public Debt on Private Investment in Developing Economies, 2024, World Bank Group MENA. Available here
- Diverting Development: The G20 and External Debt Service Burden in Africa, 2025. Available here
- South African National Survey of Research and Experimental Development: Statistical Report, 2023/24, Department of Science and Innovation (DSI) & Human Sciences Research Council (HSRC). Available here
- Innovative Approaches for Unlocking R&D Funding in Africa, 2023. Available here
- From Dependency to Resilience: Why local funders are Africa’s best hope, 2025. Available here
- Policy Alignment in Enhancing Research Collaboration in Africa, 2025, International Journal of Research and Scientific Innovation (IJRSI). Available here
- Africa’s article output grows, but R&D funding is lacking, 2023, University World News. Available here
- Why African Research Stays on the Shelf — And How to Turn It Into Real-World Innovations, 2025, LinkedIn. Available here
- Role of Technology Transfer Offices in Patenting and Commercialization of Research Results in Public Funded University: Case of South Africa, 2026, ResearchGate. Available here
- ARIPO: promoting innovation in Africa, 2019, WIPO. Available here
- IP Systems in Africa, 2021, UNESCO. Available here
- Ideas to Jobs: Harnessing Intellectual Property Rights to Scale Local SME Innovation, 2025, AFRIPOLI. Available here
- Structuring Innovation Activities in Moroccan Public Universities: Proposal of a Procedures Manual, 2025, ResearchGate. Available here
- Academic scientists mobility: The hidden pipe of tacit knowledge transfer from academia to industry and to its national ecosystem, 2022, HAL Open Science. Available here
- Knowledge transfer in university–industry research partnerships: a review, 2018, The Journal of Technology Transfer. Available here
- Assessing the industrial PhD: Stakeholder insights, 2018, ResearchGate. Available here
- The Blended Finance Market: A Growth Opportunity for Banks to Build, 2025. Available here
- Venture Capital in Africa Report, 2025, AVCA. Available here
- Financing and Business Model Archetypes as Predictors of Early Survival in European Sustainable Startups, 2025, Sustainability MDPI. Available here
- The Role of Blended Finance in an Evolving Global Context, 2025, World Bank Group. Available here
- Bridging The Gap: Why Africa Needs Smarter Investment Models, 2025. Available here
- The role of guarantees in blended finance, 2021, OECD. Available here
- Public procurement and innovation: a systematic literature review, 2020, ResearchGate. Available here